Griffin M R, Smalley W E
Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2637, USA.
J Clin Gastroenterol. 1995;21 Suppl 1:S113-9.
We used a large computerized data base to study the relationship between exposure to nonsteroidal anti-inflammatory drugs (NSAIDs), anticoagulants, and corticosteroids and development of complications of peptic ulcer disease. In addition to contributing to the information on the etiology of ulcer disease, these studies offer some clues regarding the phenomenon of mucosal protection. Our series of studies indicate that mucosal adaptation to NSAIDs is of little clinical importance, that NSAIDs are associated with a strong dose-response effect that is probably more important than any between-drug differences, and that there are no "safe" NSAIDs. In addition, our data suggest that the effects of NSAIDs are mediated through mechanisms other than merely their antiplatelet effect, as they cause a different spectrum of disease than anticoagulants, and that the ulcerogenic effects of NSAIDs and corticosteroids are probably mediated through separate mechanisms as well. The effects of these drugs are synergistic, such that the combination of NSAIDs with anticoagulants or corticosteroids puts patients at a very high risk for serious ulcer disease.
我们使用一个大型计算机数据库来研究非甾体抗炎药(NSAIDs)、抗凝剂和皮质类固醇的暴露与消化性溃疡疾病并发症发生之间的关系。除了有助于了解溃疡病的病因信息外,这些研究还提供了一些关于黏膜保护现象的线索。我们的一系列研究表明,黏膜对NSAIDs的适应性在临床上意义不大,NSAIDs具有很强的剂量反应效应,这可能比药物之间的任何差异都更重要,而且不存在“安全的”NSAIDs。此外,我们的数据表明,NSAIDs的作用不仅仅是通过其抗血小板作用介导的,因为它们导致的疾病谱与抗凝剂不同,而且NSAIDs和皮质类固醇的致溃疡作用可能也是通过不同的机制介导的。这些药物的作用是协同的,因此NSAIDs与抗凝剂或皮质类固醇联合使用会使患者面临严重溃疡病的极高风险。